This activity is supported by an educational grant from GlaxoSmithKline.
This activity includes Patient Counseling Videos.
Program Description
The herpes zoster (HZ) virus, commonly known as shingles, is a reactivation of the varicella zoster virus (VZV), which causes chickenpox. Shingles is a vaccine-preventable disease with 1 currently approved zoster vaccine available for patients at risk. Pharmacists should be equipped to address patient questions about safety and efficacy of the HZ vaccine as well as identify patients who are eligible for HZ vaccination, which now includes individuals aged 19 years and older who are immunocompromised and those receiving certain drugs and treatments, such as patients with cancer. In this expanded patient population, it will be imperative for pharmacists to educate at-risk patients about the disease burden of shingles and the importance of completing the HZ vaccine series. This article will highlight strategies for pharmacists to employ to enhance patient awareness of shingles and provide individualized patient recommendations to increase vaccination rates. This activity will also include patient counseling videos to emphasize key counseling points for patients including addressing vaccine hesitancy.
Target Audience: Health system pharmacist, retail pharmacist, specialty pharmacist, pharmacy technician
Activity type: Application
Release date: November 1, 2022
Expiration date: November 1, 2023
Estimated time to complete activity: 2.0 hours
Fee: Free
Educational Objectives
At the completion of this activity, the participants will be able to:
- Describe disease burden and risk factors for shingles
- Recognize patients eligible for shingles vaccination
- Assist the pharmacist with strategies to increase the uptake of vaccination and series completion for shingles
Nicole C. Pezzino, PharmD, BCACP, CDCES
Director of Community Outreach & Innovation
Associate Professor of Pharmacy Practice
Wilkes University, Nesbitt School of Pharmacy
Wilkes-Barre, Pennsylvania
Director of PGY-1 Community-based Residency Program
Clinical Pharmacist
Weis Markets
Schnecksville, Pennsylvania
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEU) under the ACPE universal activity numbers 0290-0000-22-537-H06-P and 0290-0000-22-548-H06-T. The activity is available for CE credit through November 1, 2023.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, listen to the podcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Faculty
The following contributors have no relevant financial relationships with commercial interests to disclose:
Nicole C. Pezzino, PharmD, BCACP, CDCES
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Karleen Melody, PharmD; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta
Pharmacy Times® Editorial Staff—Davy James
An anonymous peer reviewer was part of the content validation and conflict resolution and has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms
